Dynamics in the Pharma and Biotech Industry: Opportunities in this Changing Environment

June 15, 2011 - PRLog -- MOUNTAIN VIEW, CA
WHEN:      Wednesday, June 22, 2011 at 1 p.m. EDT
LOCATION:   Online, with free registration
SPEAKERS:    Jennifer Brice, Industry Manager for Frost & Sullivan’s Pharmaceuticals and Biotechnology research group

The pharmaceutical and biotechnology industry is currently in a state of transition. Reorganization, mergers and acquisitions (M&As), consolidation and portfolio changes are being evaluated in order to maintain growth centers in the face of a myriad of serious challenges.  

Highlights of the briefing include major patent expirations, biosimilar market discussions, overview of therapeutic category shifts, generic company’s sales growth, and examples of pharmaceutical and biotechnological consolidation.

This briefing will benefit industry executives interested in pharmaceuticals and biotechnology including strategic planners, business development managers, research staff, marketing managers, as well as the investment and medical communities.

Supporting Quotes
“The current pharmaceutical/biotech industry is faced with a number of challenges,” said Industry Manager Jennifer Brice.  “These include patent expiries of major branded products, increasing presence of generics and pricing pressures, problematic intellectual property challenges for brands, increased Food and Drug Administration scrutiny and fewer approvals, declining pipeline development, research and development risk, and lower productivity.  As a result, further consolidation in the pharmaceutical and biotechnology industry is expected.”


Supporting Resources
For more information about Frost & Sullivan’s Healthcare practice, please visit: http://www.frost.com/healthcare

Registration
•   To attend the briefing, e-mail britni.myers@frost.com your full name, job title, company name, company telephone number, company email address and Web site, city, state and country.
•   Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

# # #

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's research and consulting services empower clients to generate, evaluate, and implement effective growth strategies.